119 related articles for article (PubMed ID: 36200797)
1. Role of genetic variations of DNA damage response pathway genes and heat-shock proteins in increased head and neck cancer risk.
Mahjabeen I; Sheshe S; Shakoor T; Hussain MZ; Rizwan M; Mehmood A; Haris MS; Fazal F; Burki A; Kayani MA
Future Oncol; 2022 Oct; 18(31):3519-3535. PubMed ID: 36200797
[TBL] [Abstract][Full Text] [Related]
2. Genetic and expressional variations of APEX1 are associated with increased risk of head and neck cancer.
Mahjabeen I; Baig RM; Sabir M; Kayani MA
Mutagenesis; 2013 Mar; 28(2):213-8. PubMed ID: 23408843
[TBL] [Abstract][Full Text] [Related]
3. Assessment of DNA repair susceptibility genes identified by whole exome sequencing in head and neck cancer.
Das R; Kundu S; Laskar S; Choudhury Y; Ghosh SK
DNA Repair (Amst); 2018; 66-67():50-63. PubMed ID: 29747023
[TBL] [Abstract][Full Text] [Related]
4. HPV-mediated regulation of SMAD4 modulates the DNA damage response in head and neck cancer.
Citro S; Miccolo C; Medda A; Ghiani L; Tagliabue M; Ansarin M; Chiocca S
J Exp Clin Cancer Res; 2022 Feb; 41(1):59. PubMed ID: 35144669
[TBL] [Abstract][Full Text] [Related]
5. DNA repair gene polymorphisms and risk of head and neck cancer in the Tunisian population.
Khlifi R; Kallel I; Hammami B; Hamza-Chaffai A; Rebai A
J Oral Pathol Med; 2014 Mar; 43(3):217-24. PubMed ID: 24020925
[TBL] [Abstract][Full Text] [Related]
6.
Das R; Kundu S; Laskar S; Choudhury Y; Ghosh SK
J Biomol Struct Dyn; 2023 Apr; 41(6):2090-2107. PubMed ID: 35037836
[TBL] [Abstract][Full Text] [Related]
7. Relationship of single nucleotide polymorphisms and haplotype interaction of mitochondrial unfolded protein response pathway genes with head and neck cancer.
Ahmed MW; Mahjabeen I; Gul S; Khursheed A; Mehmood A; Kayani MA
Future Oncol; 2019 Nov; 15(33):3819-3829. PubMed ID: 31651195
[No Abstract] [Full Text] [Related]
8. MDM2 and TP53 Polymorphisms as Predictive Markers for Head and Neck Cancer in Northeast Indian Population: Effect of Gene-Gene and Gene-Environment Interactions.
Bhowmik A; Das S; Bhattacharjee A; Choudhury B; Naiding M; Deka S; Ghosh SK; Choudhury Y
Asian Pac J Cancer Prev; 2015; 16(14):5767-72. PubMed ID: 26320449
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer.
Lee WT; Huang CC; Chen KC; Wong TY; Ou CY; Tsai ST; Yen CJ; Fang SY; Lo HI; Wu YH; Hsueh WT; Yang MW; Lin FC; Hsiao JR; Huang JS; Chang JY; Chang KY; Wu SY; Lin CL; Wang YH; Weng YL; Yang HC; Chang JS
Oral Dis; 2015 Mar; 21(2):207-15. PubMed ID: 24724948
[TBL] [Abstract][Full Text] [Related]
10. Association of RAD 51 135 G/C, 172 G/T and XRCC3 Thr241Met gene polymorphisms with increased risk of head and neck cancer.
Kayani MA; Khan S; Baig RM; Mahjabeen I
Asian Pac J Cancer Prev; 2014; 15(23):10457-62. PubMed ID: 25556492
[TBL] [Abstract][Full Text] [Related]
11. Haplotype analysis of XRCC2 gene polymorphisms and association with increased risk of head and neck cancer.
Saeed S; Mahjabeen I; Sarwar R; Bashir K; Kayani MA
Sci Rep; 2017 Oct; 7(1):13210. PubMed ID: 29038438
[TBL] [Abstract][Full Text] [Related]
12. Association of CYP1A1 and CYP2D6 gene polymorphisms with head and neck cancer in Tunisian patients.
Khlifi R; Chakroun A; Hamza-Chaffai A; Rebai A
Mol Biol Rep; 2014; 41(4):2591-600. PubMed ID: 24449363
[TBL] [Abstract][Full Text] [Related]
13. NF-κB1 Intronic Region Polymorphisms as Risk Factor for Head and Neck Cancer in HPV-Infected Population from Pakistan.
Sarwar S; Tareen MU; Sabir M; Sultan A; Malik SA
Curr Mol Med; 2022; 22(1):74-82. PubMed ID: 33653249
[TBL] [Abstract][Full Text] [Related]
14. Association of X-ray repair cross-complementing group 1 Arg194Trp, Arg399Gln and Arg280His polymorphisms with head and neck cancer susceptibility: a meta-analysis.
Wu W; Liu L; Yin Z; Guan P; Li X; Zhou B
PLoS One; 2014; 9(1):e86798. PubMed ID: 24497981
[TBL] [Abstract][Full Text] [Related]
15. Significance of cyclin D1 polymorphisms in patients with head and neck cancer.
Sabir M; Baig RM; Mahjabeen I; Kayani MA
Int J Biol Markers; 2013 Apr; 28(1):49-55. PubMed ID: 23125009
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of the XPC gene may contribute to the risk of head and neck cancer: a meta-analysis.
Zhang Y; Li Z; Zhong Q; Zhou W; Chen X; Chen X; Fang J; Huang Z
Tumour Biol; 2014 Apr; 35(4):3917-31. PubMed ID: 24338715
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of MMP2, MMP3, and MMP9 promoter polymorphisms and head and neck cancer risk.
Zhang C; Li C; Zhu M; Zhang Q; Xie Z; Niu G; Song X; Jin L; Li G; Zheng H
PLoS One; 2013; 8(4):e62023. PubMed ID: 23637955
[TBL] [Abstract][Full Text] [Related]
18. The Association Between the XRCC1 Arg399Gln Polymorphism and the Risk of Head and Neck Cancer: An Updated Meta-Analysis Including 14586 Subjects.
Xia S; Wu S; Wang M
Technol Cancer Res Treat; 2021; 20():15330338211033060. PubMed ID: 34278875
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in alcohol metabolizing genes and the risk of head and neck cancer in a Brazilian population.
Garcia SM; Curioni OA; de Carvalho MB; Gattás GJ
Alcohol Alcohol; 2010; 45(1):6-12. PubMed ID: 19887496
[TBL] [Abstract][Full Text] [Related]
20. Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer: Comparison with cervical cancer.
Ekanayake Weeramange C; Shu D; Tang KD; Batra J; Ladwa R; Kenny L; Vasani S; Frazer IH; Dolcetti R; Ellis JJ; Sturm RA; Leo P; Punyadeera C
Cancer; 2022 May; 128(10):1937-1947. PubMed ID: 35176174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
